Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Mahipal

Showing results (41-50 of 179) with videos related to

Pageof 18
Sort By:
Pharmacology & Therapeutics|March 5, 2021
TAS-102: A resurrected novel Fluoropyrimidine with expanding role in the treatment of gastrointestinal malignanciesSakti Chakrabarti, Grant Wintheiser, Sri Harsha Tella, et al.
Critical Reviews in Oncology/Hematology|September 22, 2020
Prevention and treatment of FGFR inhibitor-associated toxicitiesAmit Mahipal, Sri Harsha Tella, Anuhya Kommalapati, et al.
Cancer Treatment Reviews|July 1, 2019
FGFR2 genomic aberrations: Achilles heel in the management of advanced cholangiocarcinomaAmit Mahipal, Sri Harsha Tella, Anuhya Kommalapati, et al.
Cancers|August 2, 2019
Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?Amit Mahipal, Sri Harsha Tella, Anuhya Kommalapati, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa women's health studyAmit Mahipal, Kristin E Anderson, Paul J Limburg, et al.
Cancers|July 2, 2021
FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical PracticeAnuhya Kommalapati, Sri Harsha Tella, Mitesh Borad, et al.
Journal of Gastrointestinal Oncology|March 14, 2023
A glimpse into the future of esophageal carcinoma in the United States: predicting the future incidence until 2040 based on the current epidemiological dataSri Harsha Tella, Kristin Mara, Sakti Chakrabarti, et al.
Plos One|March 12, 2016
Effect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the LiteratureChenwi M Ambe, Amit Mahipal, Jimmy Fulp, et al.
American Journal of Clinical Oncology|January 23, 2016
Use of Radiation Therapy in Locally Advanced Pancreatic Cancer Improves Survival: A SEER Database AnalysisMonique Sajjad, Sachin Batra, Sarah Hoffe, et al.
JCO Precision Oncology|April 16, 2025
Safety and Efficacy of Anti-Human Epidermal Growth Factor 2 Agents in the Treatment of Biliary Tract Cancers: A Systematic ReviewNikolas Naleid, Omkar Pawar, Sakti Chakrabarti, et al.
Pageof 18

Showing results (41-50 of 179) with videos related to

Sort By:
Pageof 18
Pharmacology & Therapeutics|March 5, 2021
TAS-102: A resurrected novel Fluoropyrimidine with expanding role in the treatment of gastrointestinal malignanciesSakti Chakrabarti, Grant Wintheiser, Sri Harsha Tella, et al.
Critical Reviews in Oncology/Hematology|September 22, 2020
Prevention and treatment of FGFR inhibitor-associated toxicitiesAmit Mahipal, Sri Harsha Tella, Anuhya Kommalapati, et al.
Cancer Treatment Reviews|July 1, 2019
FGFR2 genomic aberrations: Achilles heel in the management of advanced cholangiocarcinomaAmit Mahipal, Sri Harsha Tella, Anuhya Kommalapati, et al.
Cancers|August 2, 2019
Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?Amit Mahipal, Sri Harsha Tella, Anuhya Kommalapati, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa women's health studyAmit Mahipal, Kristin E Anderson, Paul J Limburg, et al.
Cancers|July 2, 2021
FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical PracticeAnuhya Kommalapati, Sri Harsha Tella, Mitesh Borad, et al.
Journal of Gastrointestinal Oncology|March 14, 2023
A glimpse into the future of esophageal carcinoma in the United States: predicting the future incidence until 2040 based on the current epidemiological dataSri Harsha Tella, Kristin Mara, Sakti Chakrabarti, et al.
Plos One|March 12, 2016
Effect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the LiteratureChenwi M Ambe, Amit Mahipal, Jimmy Fulp, et al.
American Journal of Clinical Oncology|January 23, 2016
Use of Radiation Therapy in Locally Advanced Pancreatic Cancer Improves Survival: A SEER Database AnalysisMonique Sajjad, Sachin Batra, Sarah Hoffe, et al.
JCO Precision Oncology|April 16, 2025
Safety and Efficacy of Anti-Human Epidermal Growth Factor 2 Agents in the Treatment of Biliary Tract Cancers: A Systematic ReviewNikolas Naleid, Omkar Pawar, Sakti Chakrabarti, et al.
Pageof 18